If you are an adult with Crohn’s disease (CD), you may be eligible for the ExoFlo study evaluating the safety and efficacy of an investigational cell derived therapeutic in patients not responding to conventional therapy. These trials are being sponsored by Direct Biologics and its Chief Medical Officer, Dr. Amy Lightner. Click here to learn more: https://bit.ly/466N5Bs #ClinicalResearch #CrohnsDisease #sponsored #CD #RegenerativeMedicine #CellTherapy #ExtracellularVesicles
Direct Biologics
生物技术研究
Austin,Texas 4,333 位关注者
Direct Biologics is a market-leading innovator in regenerative medicine.
关于我们
Direct Biologics is a market-leading innovator in regenerative medicine.
- 网站
-
https://www.directbiologics.com
Direct Biologics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Austin,Texas
- 类型
- 私人持股
地点
-
主要
1529 Barton Springs Rd
Suite 31
US,Texas,Austin,78704